Hypermethylation of Death-Associated Protein Kinase 1 differentiates natural killer cell lines from cell lines derived from T-acute lymphoblastic leukemia

Leukemia

Volumn 23, Issue 6, 2009, Pages 1174-1176

  Rohrs S ^a   Romani, J ^a   Zaborski, M ^a   Drexler, H G ^a   Quentmeier, H ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE 1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CONTROLLED STUDY; CPG ISLAND; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NATURAL KILLER CELL; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN METHYLATION; T CELL LEUKEMIA; TUMOR SUPPRESSOR GENE;

EID: 67349113867     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2009.5     Document Type: Article

References (17)

1. Matsuo Y, Drexler HG. Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma. Leuk Res 2003; 27: 935-945.
2. Matsuo Y, Drexler HG, Harashima A, Okochi A, Shimizu N, Orita K. Transcription factor expression in cell lines derived from natural killer-cell and natural-killer T-cell leukemia-lymphoma. Hum Cell 2004; 17: 85-92.
3. Nygren AOH, Ameziane N, Duarte HMB, Vijzelaar RNCP, Waisfisz Q, Hess CJ et al. Methylation-specific MLPA (MS-MLPA): Simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res 2005; 33: E128.
4. Esteller M. Epigenetics in cancer. N Engl J Med 2008; 358: 1148-1159.
5. Costello JF, Frühwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000; 25: 132-138.
6. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 3225-3229.
7. Esteller M. Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg. Clin Immunol 2003; 109: 80-88.
8. Rahmatpanah FB, Carstens S, Guo J, Sjahputera O, Taylor KH, Duft D et al. Differential DNA methylation patterns of small B-cell lymphoma subclasses with different clinical behavior. Leukemia 2006; 10 1855-1862.
9. Shi H, Guo J, Duff DJ, Rahmatpanah FB, Chitima-Matsiga R, Al-Kuhlani M et al. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma. Carcinogenesis 2007; 28: 60-70.
10. Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi A. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the g interferon-induced cell death. Genes Dev 1995; 9: 15-30.
11. Cohen O, Inbal B, Kissil JL, Raveh T, Berissi H, Spivak-Kroizaman T et al. DAP-Kinase participates in TNF- and RAS-induced apoptosis and its function requires the death domain. J Cell Biol 1999; 146 141-148.
12. Drexler HG. Guide to Leukemia-Lymphoma Cell Lines. Braunschweig, 2005.
13. Nakatsuka S, Takakuwa T, Tomita Y, Hoshida Y, Nishiu M, Yamaguchi M et al. Hypermethylation of death-associated protein (DAP) kinase CpG island is frequent not only in B-cell but also in T- and natural killer (NK)/T-cell malignancies. Cancer Sci 2003; 94: 87-91.
14. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Prosper F, Heiniger A, Torres A. Lack of CpG Island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. J Clin Oncol 2005; 23: 7043-7049.
15. Cross SH, Bird AP. CpG islands and genes. Curr Opin Genet Dev 1995; 5: 309-314.
16. Esteller M. CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future. Oncogene 2002; 21: 5427-5440.
17. Puto LA, Reed JC. Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation. Genes Dev 2008; 22: 998-1010.